Operating Segments was the largest of Prestige Consumer Healthcare Inc.’s 2 reported lines in fiscal 2025, at $960.01M — 100% of $963.91M.
| Segment | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Operating Segments | $973.77M | $958.26M | $960.01M | ||||
| Intersegment Eliminations | $4.30M | $3.70M | $3.90M | ||||
| Eliminations | — | — | — | ||||
| Total | $978.07M | $961.96M | $963.91M |
In fiscal 2025, which ended March 31, 2025, the 2 segments Prestige Consumer Healthcare Inc. reported in this breakdown added up to $963.91M. That is less than the $1.14B in its breakdown by region, so these segments do not account for all of its revenue that year. Operating Segments was the largest segment, at $960.01M or 99.6% of the total, followed by Intersegment Eliminations ($3.90M, 0.4%).
The table also keeps 1 segment that Prestige Consumer Healthcare Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 1 discontinued" beneath the table to see them. This breakdown covers 7 fiscal years between 2014 and 2025, as reported in Prestige Consumer Healthcare Inc.'s annual filings.
United States was the largest of Prestige Consumer Healthcare Inc.’s 2 reported lines in fiscal 2025, at $897.54M — 79% of $1.14B.
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $910.11M | $953.22M | $886.47M | $897.54M | ||||||
| Rest Of World | $176.71M | $174.50M | $238.89M | $240.22M | ||||||
| Total | $1.09B | $1.13B | $1.13B | $1.14B |
In fiscal 2025, which ended March 31, 2025, the 2 regions Prestige Consumer Healthcare Inc. reported in this breakdown added up to $1.14B. That was up 1.1% from $1.13B in fiscal 2024. United States was the largest region, at $897.54M or 78.9% of the total, followed by Rest Of World ($240.22M, 21.1%).
Compared with fiscal 2024, United States grew the fastest, rising 1.2% to $897.54M. Over fiscal 2022 to 2025, revenue across these regions went from $1.09B to $1.14B, a compound annual growth rate of 1.5%. United States' share of the total fell from 83.7% to 78.9% over the same years.
This breakdown covers every fiscal year from 2016 to 2025, as reported in Prestige Consumer Healthcare Inc.'s annual filings.
Combined Subsidiary Guarantors was the largest of Prestige Consumer Healthcare Inc.’s 3 reported lines in fiscal 2017, at $708.34M — 80% of $885.31M.
| Legal Entity | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Combined Subsidiary Guarantors | $479.22M | $555.39M | $643.33M | $708.34M | |||
| Prestige Brands, Inc., The Issuer | $97.80M | $106.44M | $111.75M | $112.56M | |||
| Combined Non-Guarantor Subsidiaries | $24.93M | $51.63M | $50.67M | $64.42M | |||
| Eliminations | -$4.57M | — | — | — | |||
| Total | $597.38M | $713.46M | $805.75M | $885.31M |
In fiscal 2017, which ended March 31, 2017, the 3 revenue lines Prestige Consumer Healthcare Inc. reported in this breakdown added up to $885.31M. That was up 9.9% from $805.75M in fiscal 2016. Combined Subsidiary Guarantors was the largest revenue line, at $708.34M or 80.0% of the total, followed by Prestige Brands, Inc., The Issuer ($112.56M, 12.7%) and Combined Non-Guarantor Subsidiaries ($64.42M, 7.3%). Together, the two largest revenue lines made up 92.7% of this total.
Compared with fiscal 2016, Combined Non-Guarantor Subsidiaries grew the fastest, rising 27.1% to $64.42M. Every sizeable revenue line reported in both years grew.
The table also keeps 1 revenue line that Prestige Consumer Healthcare Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 1 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2011 to 2017, as reported in Prestige Consumer Healthcare Inc.'s annual filings.
Prestige Consumer Healthcare Inc. (PBH) breaks its revenue down by segment, region and revenue line. In fiscal 2025, its largest segment was Operating Segments, with $960.01M or 99.6% of the total, followed by Intersegment Eliminations at $3.90M (0.4%).
Operating Segments was Prestige Consumer Healthcare Inc.'s largest segment in fiscal 2025, with $960.01M in revenue, 99.6% of the $963.91M reported across its 2 segments.
United States was Prestige Consumer Healthcare Inc.'s largest region in fiscal 2025, with $897.54M in revenue, 78.9% of the $1.14B reported across its 2 regions.
Combined Subsidiary Guarantors was Prestige Consumer Healthcare Inc.'s largest revenue line in fiscal 2017, with $708.34M in revenue, 80.0% of the $885.31M reported across its 3 revenue lines.
Of the Prestige Consumer Healthcare Inc. regions reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, United States grew the fastest, rising 1.2% from $886.47M to $897.54M.
Every figure is taken from Prestige Consumer Healthcare Inc.'s annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2014 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.